Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Developer of catheters designed to treat Coronary Artery Disease (CAD) and bifurcation vascular disease. The company's catheters are drug-eluting ostium protection devices for the treatment of coronary artery lesions located at a bifurcation and ostium, enabling healthcare providers to treat coronary artery diseases.

Formerly Known As
Cappella Medical Devices
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Primary Office
  • 2 Ballybrit Business Park
  • Galway H91 DT7C
  • Ireland

+353 (091) 000 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ArraVasc’s full profile, request a free trial.

ArraVasc Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 13-May-2018 000.00 Completed Out of Business
6. Later Stage VC 01-Jan-2017 00000 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 12-Mar-2015 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 21-Feb-2011 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 15-Jun-2009 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 01-Jan-2007 $4.94M $11.9M Completed Generating Revenue
1. Early Stage VC $6.97M $6.97M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ArraVasc Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VytronUS Venture Capital-Backed Sunnyvale, CA 00 00000 00000000000 00000
000000000000 Formerly VC-backed Morrisville, NC 000 00000 00000000000 00000
0000000000 Formerly VC-backed Fremont, CA 000 000.00 000000&0 000.00
0000000000 Formerly VC-backed Mountain View, CA 000.00 000000&0 000.00
0000000 Private Equity-Backed Burnaby, Canada 00 00.000 0000000 0000 00.000
To view this company’s complete list of competitors, request access »